Compound Detail
CHEMBL6030719
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL6030719 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | RIEDGQLYSUVDKT-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
0
Publications
0
Known Names
Molecular Properties
365.5
MW (Da)
3.43
ALogP
3
HBA
2
HBD
61.4
PSA (Ų)
0.82
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 8.81
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Integrin alpha-4/beta-7 CHEMBL2095184 | IC50 | 8.81 | 8.81 | 1.5 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Integrin alpha-4/beta-7 | IC50 | = | 1.53 | nM | 8.81 | ELISA assay : The studies began by screening for the optimal protein concentrati... | - |
Data from ChEMBL 36 via Core Engine